Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 How to determine GBeta  





2 Clinical significance  



2.1  Validity  





2.2  Reliability  





2.3  Clinical utility  







3 Scientific implications and other uses  





4 Pathophysiological implications  





5 See also  





6 Notes  





7 References  





8 External links  














SPINA-GBeta






Deutsch
Español
 

Edit links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 
















Appearance
   

 






From Wikipedia, the free encyclopedia
 


SPINA-GBeta
Reference range0.64–3.73 pmol/s
Calculatorhttps://doi.org/10.5281/zenodo.7479856
PurposeMedical diagnosis, research
Test ofPancreatic beta cell function

SPINA-GBeta is a calculated biomarker for pancreatic beta cell function.[1][a] It represents the maximum amount of insulin that beta cells can produce per time-unit (e.g. in one second).

How to determine GBeta[edit]

The index is derived from a mathematical model of insulin-glucose homeostasis.[2] For diagnostic purposes, it is calculated from fasting insulin and glucose concentrations with:

.[1]

[I](∞): Fasting Insulin plasma concentration (μU/mL)
[G](∞): Fasting blood glucose concentration (mg/dL)
Dβ: EC50 for glucose at beta cells (7 mmol/L)
G3: Parameter for pharmacokinetics (58,8 s/L)

Clinical significance[edit]

Validity[edit]

SPINA-GBeta significantly correlates with the M value in glucose clamp studies and (better than HOMA-Beta) with the two-hour value in oral glucose tolerance testing (OGTT), glucose rise in OGTT, subscapular skinfold, truncal fat content and the HbA1c fraction.[1]

It has the additional advantage that it circumvents the HOMA-blind zone, which renders the calculation of HOMA-Beta impossible if the fasting glucose concentration is 3.5 mmol/L (63 mg/dL) or below.[3] Unlike HOMA-Beta, SPINA-Beta can be sensibly calculated in the whole range of measurements.[1]

Reliability[edit]

In repeated measurements, SPINA-GBeta had higher retest reliability than HOMA-Beta, a measurement for beta cell function from the homeostasis model assessment.[1][4]

Clinical utility[edit]

In the FAST study, an observational case-control sequencing study including 300 persons from Germany, SPINA-GBeta differed more clearly between subjects with and without diabetes than the corresponding HOMA-Beta index.[4]

Scientific implications and other uses[edit]

Together with the reconstructed insulin receptor gain (SPINA-GR), SPINA-GBeta provides the foundation for the definition of a fasting based disposition index of insulin-glucose homeostasis (SPINA-DI).[4]

In combination with SPINA-GR and whole-exome sequencing, calculating SPINA-GBeta helped to identify a new form of monogenetic diabetes (MODY) that is characterised by primary insulin resistance and results from a missense variant of the type 2 ryanodine receptor (RyR2) gene (p.N2291D).[5]

Pathophysiological implications[edit]

In several populations, SPINA-GBeta correlated with the area under the glucose curve and 2-hour concentrations of glucose, insulin and proinsulin in oral glucose tolerance testing, concentrations of free fatty acids, ghrelin and adiponectin, and the HbA1c fraction.[4]

See also[edit]

Notes[edit]

  1. ^ SPINA is an acronym for "structure parameter inference approach".

References[edit]

  1. ^ a b c d e Dietrich, JW; Dasgupta, R; Anoop, S; Jebasingh, F; Kurian, ME; Inbakumari, M; Boehm, BO; Thomas, N (21 October 2022). "SPINA Carb: a simple mathematical model supporting fast in-vivo estimation of insulin sensitivity and beta cell function". Scientific Reports. 12 (1): 17659. Bibcode:2022NatSR..1217659D. doi:10.1038/s41598-022-22531-3. PMC 9587026. PMID 36271244.
  • ^ Dietrich, Johannes W.; Böhm, Bernhard (27 August 2015). "Die MiMe-NoCoDI-Plattform: Ein Ansatz für die Modellierung biologischer Regelkreise". GMDS 2015; 60. Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik: Biometrie und Epidemiologie e.V. (GMDS). doi:10.3205/15gmds058.
  • ^ Cersosimo, E; Solis-Herrera, C; Trautmann, ME; Malloy, J; Triplitt, CL (January 2014). "Assessment of pancreatic β-cell function: review of methods and clinical applications". Current Diabetes Reviews. 10 (1): 2–42. doi:10.2174/1573399810666140214093600. PMC 3982570. PMID 24524730.
  • ^ a b c d Dietrich, Johannes W.; Abood, Assjana; Dasgupta, Riddhi; Anoop, Shajith; Jebasingh, Felix K.; Spurgeon, R.; Thomas, Nihal; Boehm, Bernhard O. (2 January 2024). "A novel simple disposition index ( SPINA-DI ) from fasting insulin and glucose concentration as a robust measure of carbohydrate homeostasis". Journal of Diabetes. doi:10.1111/1753-0407.13525. PMID 38169110. S2CID 266752689.
  • ^ Bansal, Vikas; Winkelmann, Bernhard R.; Dietrich, Johannes W.; Boehm, Bernhard O. (20 February 2024). "Whole-exome sequencing in familial type 2 diabetes identifies an atypical missense variant in the RyR2 gene". Frontiers in Endocrinology. 15. doi:10.3389/fendo.2024.1258982. PMC 10913019. PMID 38444585.
  • External links[edit]


    Retrieved from "https://en.wikipedia.org/w/index.php?title=SPINA-GBeta&oldid=1221895381"

    Categories: 
    Diabetes
    Endocrinology
    Human homeostasis
    Endocrine procedures
    Static endocrine function tests
    Hidden categories: 
    Articles with short description
    Short description is different from Wikidata
     



    This page was last edited on 2 May 2024, at 16:57 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki